Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
47,970,593
-
Total 13F shares
-
27,974,679
-
Share change
-
+2,530,806
-
Total reported value
-
$1,245,142,856
-
Put/Call ratio
-
21%
-
Price per share
-
$44.51
-
Number of holders
-
130
-
Value change
-
+$121,341,493
-
Number of buys
-
79
-
Number of sells
-
58
Institutional Holders of BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) as of Q2 2021
As of 30 Jun 2021,
BIOLIFE SOLUTIONS INC - COMMON STOCK (BLFS) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,974,679 shares.
The largest 10 holders included
Casdin Capital, LLC, BlackRock Inc., MARSHALL WACE, LLP, VANGUARD GROUP INC, WASATCH ADVISORS INC, GENEVA CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, Ranger Investment Management, L.P., STATE STREET CORP, and MILLENNIUM MANAGEMENT LLC.
This page lists
130
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.